Skip to main content

Table 2 Distribution of drug concentrations by cases and controls

From: Antiretroviral concentration measurements as an additional tool to manage virologic failure in resource limited settings: a case control study

Drug

Cases

Controls

P-value*

N

Median (IQR)

N

Median (IQR)

Nevirapine

65

5.37 (2.81–7.64)

116

8.18 (6.38–12.69)

< 0.01

Efavirenz

77

1.60 (0.00–2.50)

221

2.72 (1.78–4.71)

< 0.01

Lopinavir

34

6.41 (0.00–10.70)

24

9.84 (5.54–13.57)

0.06

Atazanavir

15

0.00 (0.00–1.44)

21

2.50 (1.29–3.24)

0.01

  1. *P-values comparing median drug concentrations between cases and controls using Mann–Whitney Wilcoxon rank-sum test. Significant differences were observed in concentrations of nevirapine, efavirenz and atazanavir